Greenland Mines Ltd. (GRML) Stock Ticker
GRML right now
Market factors today
Unlock the full GRML picture
About Greenland Mines Ltd.
Greenland Mines Ltd operates across two segments: natural resources and cell and gene therapy. Its resources arm is focused on exploring for palladium, gold, and platinum, centered on the exploration and development of the Skaergaard project in Southeast Greenland. On the therapeutics side, the company is developing KLTO-202, a gene therapy targeting the treatment and prevention of amyotrophic lateral sclerosis (ALS), and KLTO-101, aimed at treating or preventing Alzheimer's disease, alongside therapies for Parkinson's and other age-related conditions. Previously known as Klotho Neurosciences, Inc., the company adopted its current name in March 2026. It is headquartered in Charlotte, North Carolina.
GRML stock facts
| Ticker symbol | GRML |
| Exchange | NASDAQ Global Market |
| Sector | Basic Materials |
| Industry | Other Precious Metals |
| Market cap | $44.1M |
| CEO | Joseph A. Sinkule |
| Employees | 5 |
| Headquarters | Charlotte, NE, US |
| IPO date | 2022-04-29 |
| Website | greenlandmines.com |
What you can see for GRML on Tickr
Live GRML price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the GRML report.
Rankings
FAQ
What is the ticker symbol for Greenland Mines Ltd.?
The ticker symbol for Greenland Mines Ltd. is GRML, listed on the NASDAQ Global Market.
What is GRML?
Greenland Mines Ltd operates across two segments: natural resources and cell and gene therapy. Its resources arm is focused on exploring for palladium, gold, and platinum, centered on the exploration and development of the Skaergaard project in Southeast Greenland. On the therapeutics side, the company is developing KLTO-202, a gene therapy targeting the treatment and prevention of amyotrophic…